BMY Related Downgrades

Mar 4, 2013 07:04 AM BofA/Merrill Lynch Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral

Nov 12, 2012 07:19 AM BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform

Aug 2, 2012 10:22 AM Barclays Downgrades Bristol-Myers Squibb Co. (BMY) to Equalweight

Feb 7, 2012 11:38 AM Achillion (ACHN) Shares Rocked as BofA Cuts to Underperform

Jan 19, 2012 10:18 AM Bristol-Myers (BMY) Shares Continuing Lower as Morgan Stanley Cuts to Equalweight

Jan 9, 2012 03:24 PM JMP Cuts Idenix (IDIX) to Market Underperform, Sets $4 Price Target

Jan 9, 2012 07:31 AM Baird Downgrades Inhibitex (INHX) to Neutral; Sold to Bristol-Myers (NYSE: BMY) as Run on Hep C Continues

Oct 28, 2011 07:59 AM CLSA Downgrades Bristol-Myers Squibb Co. (BMY) to Underperform

Sep 14, 2011 12:45 PM UPDATE - Barclays Downgraded Pfizer (PFE) to Equalweight; Inferior Revenue Recovery Post 'Patent Cliff' Through 2020

May 11, 2011 06:47 AM Goldman Sachs Downgrades Bristol-Myers Squibb (BMY) to Neutral, Likes Johnson & Johnson (JNJ) More

Mar 31, 2011 07:27 AM Jefferies Downgrades Bristol-Myers Squibb (BMY) to Hold, Release of Yervoy Drives Stock Up

Feb 7, 2011 07:52 AM Cowen Upgrades Bristol-Myers (BMY) to Outperform, Downgrades Merck (MRK) to Neutral

Oct 4, 2010 09:39 AM Bristol-Myers (BMY) Downgraded to Equal Weight at Morgan Stanley

Sep 24, 2010 09:02 AM Hapoalim Cuts Bristol-Myers (BMY) to Sell

Sep 9, 2010 02:22 PM Wedbush downgrades ZymoGenetics (ZGEN) to Neutral; Bristol-Myers (BMY) Steps in at $9.75

Sep 9, 2010 10:37 AM UBS Downgrades Zymogenetics (ZGEN) to Neutral; Acquired By Bristol-Myers (BMY)

Jun 7, 2010 07:07 AM Goldman Sachs Downgrades Abbott (ABT) to Neutral

Jan 4, 2010 09:09 AM Citi Downgrades Bristol-Myers (BMY) to Hold

Oct 9, 2009 10:00 AM Cowen & Co Downgrades Bristol-Myers (BMY) to Neutral

Aug 28, 2009 08:21 AM Morgan Stanley Downgrades Bristol-Myers (BMY) to Equalweight

Apr 29, 2009 07:29 AM Goldman Sachs Downgrades Bristol-Myers Squibb (BMY) to Neutral

Apr 3, 2009 07:36 AM Bernstein Downgrades Bristol-Myers Squibb (BMY) to Market Perform

Dec 16, 2008 10:38 AM Merrill Lynch Downgrades Bristol-Myers Squibb (BMY) to Neutral

Oct 16, 2008 12:29 PM Matrix Lighthouse Rating Changes 10/16

Sep 5, 2008 09:36 AM Goldman Sachs Downgrades ImClone (IMCL) to Neutral

Aug 1, 2008 10:47 AM Matrix USA Rating Changes 8/1:

Jul 9, 2008 10:37 AM Matrix USA Rating Changes 7/9

May 12, 2008 09:32 AM Matrix USA Rating Changes 5/12

Mar 4, 2008 09:44 AM Matrix USA Rating Changes 3/4

Jan 31, 2008 03:02 PM S&P Equity Research Downgrades Bristol-Myers Squibb (BMY) to Hold

Jan 24, 2008 08:02 AM Goldman Sachs downgrades Bristol Myers Squibb Co. (BMY) to Sell

Dec 6, 2007 03:06 PM S&P Equity Research Downgrades Bristol-Myers Squibb (BMY) to Buy

Sep 4, 2007 07:38 AM Goldman Sachs downgrades Bristol-Myers (BMY) to Sell

Aug 30, 2007 10:31 AM S&P Equity Research Downgrades Medarex (MEDX) to Hold

Aug 8, 2006 03:20 PM S&P Equity Research Downgrades Bristol-Myers Squibb (BMY) to Sell

Aug 8, 2006 02:52 PM A.G. Edwards Downgrades Bristol-Myers Squibb (BMY) to Sell

Jul 28, 2006 07:46 AM JP Morgan downgrades Bristol-Myers (BMY) to Neutral

Sep 20, 2005 08:39 AM Bernstein downgrades BMY to Market Perform